Global Tuberculosis Diagnostics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

Scope of the Report:
This report focuses on the Tuberculosis Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
In the last several years, EMEA market of Tuberculosis Diagnostics developed smoothly, with an average growth rate of 4.59%. In 2017, EMEA revenue of Tuberculosis Diagnostics is nearly 854 M USD.
The classification of Tuberculosis diagnostics includes culture-based diagnostics, sputum smear microscopy diagnostics, rapid molecular diagnostics and so on. And the proportion of Culture-based Diagnostic in 2017 is about 34.84%, and the proportion is in decreasing trend from 2013 to 2017.
Europe is the largest consumption place, with a Revenue market share nearly 42.03% in 2017. Following Europe, Africa is the second largest consumption place with the Revenue market share of 35.76%.
The worldwide market for Tuberculosis Diagnostics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers
Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec
Epistem
Akonni Biosystems
Creative Diagnostics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Culture-based
Sputum Smear Microscopy
Rapid Molecular
Others

Market Segment by Applications, can be divided into
Hospital
Diagnostic Laboratories
Others

There are 15 Chapters to deeply display the global Tuberculosis Diagnostics market.
Chapter 1, to describe Tuberculosis Diagnostics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Tuberculosis Diagnostics, with sales, revenue, and price of Tuberculosis Diagnostics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Tuberculosis Diagnostics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Tuberculosis Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Tuberculosis Diagnostics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions